BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31308754)

  • 1. The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation.
    Zhou L; Zhang S; Zou X; Lu J; Yang X; Xu Z; Shan A; Jia W; Liu F; Yan X; Su H; Liang T; Zheng M; Zhang Y; Feng B
    Cancer Manag Res; 2019; 11():6185-6199. PubMed ID: 31308754
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential expression of ST6GAL1 in the tumor progression of colorectal cancer.
    Zhang S; Lu J; Xu Z; Zou X; Sun X; Xu Y; Shan A; Lu J; Yan X; Cui Y; Yan W; Du Y; Gu J; Zheng M; Feng B; Zhang Y
    Biochem Biophys Res Commun; 2017 May; 486(4):1090-1096. PubMed ID: 28377225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
    Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
    J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
    Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
    Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth.
    Gc S; Tuy K; Rickenbacker L; Jones R; Chakraborty A; Miller CR; Beierle EA; Hanumanthu VS; Tran AN; Mobley JA; Bellis SL; Hjelmeland AB
    JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36345944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade.
    Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L
    J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels.
    Lu J; Isaji T; Im S; Fukuda T; Kameyama A; Gu J
    J Biol Chem; 2016 Mar; 291(11):5708-5720. PubMed ID: 26801611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.
    Huang G; Li Z; Li Y; Liu G; Sun S; Gu J; Kameyama A; Li W; Dong W
    Biochem J; 2020 Mar; 477(6):1179-1201. PubMed ID: 32141499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
    Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
    Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics.
    Ankenbauer KE; Rao TC; Mattheyses AL; Bellis SL
    J Biol Chem; 2023 Oct; 299(10):105217. PubMed ID: 37660914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
    Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
    J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
    Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
    Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycomics reveal that ST6GAL1-mediated sialylation regulates uterine lumen closure during implantation.
    Han K; Wang F; Yue Y; Tan X; Tian M; Miao Y; Zhao S; Dong W; Yu M
    Cell Prolif; 2022 Jan; 55(1):e13169. PubMed ID: 34957619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics.
    Ankenbauer KE; Rao TC; Mattheyses AL; Bellis SL
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCCTC-binding factor: the specific transcription factor of β-galactoside α-2,6-sialyltransferase 1 that upregulates the sialylation of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Zhao H; Wang H; Qin Y; Ling S; Zhai H; Jin J; Fang L; Cao Z; Jin S; Yang X; Wang J
    Rheumatology (Oxford); 2024 Mar; 63(3):826-836. PubMed ID: 37326830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST6Gal1 in plasma is dispensable for IgG sialylation.
    Oswald DM; Lehoux SD; Zhou JY; Glendenning LM; Cummings RD; Cobb BA
    Glycobiology; 2022 Aug; 32(9):803-813. PubMed ID: 35746897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-localized ST6Gal1 does not impact IgG sialylation.
    Glendenning LM; Zhou JY; Kukan EN; Gao C; Cummings RD; Joshi S; Whiteheart SW; Cobb BA
    Glycobiology; 2023 Dec; 33(11):943-953. PubMed ID: 37379323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent Golgi trafficking limits B cell-mediated IgG sialylation.
    Glendenning LM; Zhou JY; Reynero KM; Cobb BA
    J Leukoc Biol; 2022 Dec; 112(6):1555-1566. PubMed ID: 35726710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation.
    Zhou X; Kinlough CL; Hughey RP; Jin M; Inoue H; Etling E; Modena BD; Kaminski N; Bleecker ER; Meyers DA; Jarjour NN; Trudeau JB; Holguin F; Ray A; Wenzel SE
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30730306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.
    Venturi G; Gomes Ferreira I; Pucci M; Ferracin M; Malagolini N; Chiricolo M; Dall'Olio F
    Glycobiology; 2019 Sep; 29(10):684-695. PubMed ID: 31317190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.